In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...
The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results